Medicare Part D coverage · buprenorphine · RxCUI 1716063
buprenorphine 0.15 MG Buccal Film [Belbuca]
Per the CMS 2026 Part D formulary file, buprenorphine 0.15 MG Buccal Film [Belbuca] is covered by 332 Medicare Part D plans (6.6% of enrollable products), averaging Tier 2.6, with prior authorization required on 82.5% of covering formularies.
- 6.6%
- Plan coverage
- 332
- Plans covering
- T2.6
- Avg tier
- 82.5%
- Prior auth required
What the CMS Formulary Data Shows for buprenorphine 0.15 MG Buccal Film [Belbuca]
Per the CMS 2026 Part D formulary file, buprenorphine 0.15 MG Buccal Film [Belbuca] (RxNorm concept RXCUI 1716063, generic name buprenorphine) appears on 40 distinct formulary files spanning 332 Medicare Part D plan offerings - 6.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.6.
Real-world access to buprenorphine 0.15 MG Buccal Film [Belbuca] depends on utilization management as much as tier placement: 82.5% of covering formularies require prior authorization. 0% require step therapy. 97.5% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 74,893 Part D beneficiaries filled buprenorphine 0.15 MG Buccal Film [Belbuca] in 2023, with total plan-and-beneficiary spending of $119,710,207 and an average per-beneficiary annual cost of $1,598.42. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry buprenorphine 0.15 MG Buccal Film [Belbuca] today.
Coverage Details
- Formularies covering
- 40
- Plans covering
- 332
- Coverage rate
- 6.6%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 82.5% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 97.5% of formularies
2023 Medicare Spending
- Beneficiaries
- 74,893
- Total spending
- $119,710,207
- Avg per beneficiary
- $1,598.42
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering buprenorphine 0.15 MG Buccal Film [Belbuca]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| ElderServe MAP (HMO D-SNP) | Elderserve Health, Inc. | T1 | Yes | $0 | NY |
| Cooperative Advantage (HMO D-SNP) | Group Health Cooperative OF EAU Claire | T1 | Yes | $0 | WI |
| Longevity Health Plan (PPO I-SNP) | Longevity Health Plan OF NEW Jersey Insurance Comp | T1 | Yes | $0 | NJ |
| Upper Peninsula Health Plan MI Coordinated Health (HMO D-SNP) | Upper Peninsula Health Plan, LLC | T1 | Yes | $0 | MI |
| CareSource Dual Advantage (HMO D-SNP) | Caresource Georgia Co. | T1 | Yes | $0 | GA |
| HAP CareSource MI Coordinated Health (HMO D-SNP) | HAP Caresource | T1 | Yes | $0 | MI |
| Gold Coast Health Plan Total Care Advantage (HMO D-SNP) | Ventura County Medi-Cal Managed Care Commission | T1 | Yes | $0 | CA |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Health Care Service Corporation | T1 | Yes | $0 | NM |
| Blue Cross MA Dual Care Plus Preferred (PPO D-SNP) | Health Care Service Corporation | T1 | Yes | $0 | NM |
| SecureBlue (HMO D-SNP) | HMO Minnesota | T1 | Yes | $0 | MN |
| Hamaspik Medicare Choice (HMO D-SNP) | Hamaspik, Inc. | T1 | Yes | $0 | NY |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Florida, Inc. | T1 | Yes | $4.80 | FL |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Hcsc Insurance Services Company | T1 | Yes | $4.80 | TX |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | GHS Insurance Company | T1 | Yes | $5.00 | OK |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Michigan, Inc. | T1 | Yes | $8.80 | MI |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Illinois, Inc. | T1 | Yes | $15.20 | IL |
| WellSense Added Value (HMO) | Boston Medical Center Health Plan, Inc. | T1 | Yes | $21.70 | NH |
| Hamaspik Medicare Select (HMO D-SNP) | Hamaspik, Inc. | T1 | Yes | $34.50 | NY |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Colorado, Inc. | T1 | Yes | $35.20 | CO |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF North Carolina, Inc. | T1 | Yes | $36.20 | NC |
Show the next 30 plans
| Longevity Health Plan (PPO I-SNP) | Longevity Health Plan OF NEW Jersey Insurance Comp | T1 | Yes | $40.00 | NJ |
| ElderServe Star (HMO I-SNP) | Elderserve Health, Inc. | T1 | Yes | $58.80 | NY |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF NEW York, Inc. | T1 | Yes | $58.80 | NY |
| The Health Plan SecureCare - Option II (HMO) | THE Health Plan OF West Virginia, Inc. | T3 | Yes | $0 | OH |
| The Health Plan SecureCare - Option II (HMO) | THE Health Plan OF West Virginia, Inc. | T3 | Yes | $0 | OH, WV |
| The Health Plan SecureCare Capitol Plan (HMO) | THE Health Plan OF West Virginia, Inc. | T3 | Yes | $0 | WV |
| The Health Plan SecureChoice Optimum (PPO) | THP Insurance Company | T3 | Yes | $0 | OH, WV |
| WellSense Signature (HMO) | Boston Medical Center Health Plan, Inc. | T3 | Yes | $0 | NH |
| WellSense Signature Access (PPO) | Boston Medical Center Health Plan, Inc. | T3 | Yes | $0 | NH |
| Essence Advantage (HMO) | Essence Healthcare, Inc. | T3 | Yes | $0 | IL, MO |
| Essence Advantage (HMO) | Essence Healthcare, Inc. | T3 | Yes | $0 | AR, MO |
| Essence Advantage Select (HMO) | Essence Healthcare, Inc. | T3 | Yes | $0 | IL, MO |
| Essence Advantage (HMO) | Essence Healthcare, Inc. | T3 | Yes | $0 | IN, KY |
| Essence Advantage Select (HMO) | Essence Healthcare, Inc. | T3 | Yes | $0 | IL |
| Essence Advantage Choice (PPO) | Essence Healthcare PPO, Inc. | T3 | Yes | $0 | IL, MO |
| Essence Advantage Choice (PPO) | Essence Healthcare PPO, Inc. | T3 | Yes | $0 | AR, MO |
| Essence Advantage Choice (PPO) | Essence Healthcare PPO, Inc. | T3 | Yes | $0 | IL |
| CareSource Dual Advantage Plus (HMO D-SNP) | Caresource Georgia Co. | T3 | Yes | $0 | GA |
| CareSource MyCare Ohio (HMO D-SNP) | Caresource Ohio, Inc. | T3 | Yes | $0 | OH |
| Blue adVantage Liberty (PPO) | Louisiana Health Service & Indemnity Company | T3 | Yes | $0 | LA |
| Blue adVantage Thrive (PPO) | Louisiana Health Service & Indemnity Company | T3 | Yes | $0 | LA |
| Blue adVantage Classic (HMO-POS) | HMO Louisiana, Inc. | T3 | Yes | $0 | LA |
| Blue adVantage Giveback (HMO-POS) | HMO Louisiana, Inc. | T3 | Yes | $0 | LA |
| Blue Medicare Essential Plus (HMO-POS) | Blue Cross AND Blue Shield OF North Carolina | T3 | Yes | $0 | NC |
| Blue Medicare Choice (HMO) | Blue Cross AND Blue Shield OF North Carolina | T3 | Yes | $0 | NC |
| Blue Medicare Essential (HMO) | Blue Cross AND Blue Shield OF North Carolina | T3 | Yes | $0 | NC |
| Experience Health Medicare Advantage (HMO) | Blue Cross AND Blue Shield OF North Carolina | T3 | Yes | $0 | NC |
| Healthy Blue + Medicare (HMO-POS D-SNP) | Blue Cross AND Blue Shield OF North Carolina | T3 | Yes | $0 | NC |
| Blue Advantage Complete (PPO) | Blue Cross AND Blue Shield OF Alabama | T3 | Yes | $0 | AL |
| BSW SeniorCare Advantage (PPO) | Baylor Scott & White Insurance Company | T3 | Yes | $0 | TX |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is buprenorphine 0.15 MG Buccal Film [Belbuca] covered by Medicare Part D?
Yes, buprenorphine 0.15 MG Buccal Film [Belbuca] is covered by 332 Medicare Part D plans (6.6% of all Part D formularies).
What tier is buprenorphine 0.15 MG Buccal Film [Belbuca] on Medicare Part D plans?
buprenorphine 0.15 MG Buccal Film [Belbuca] averages Tier 2.6 across Part D plans, ranging from Tier 1 to Tier 4.
Does buprenorphine 0.15 MG Buccal Film [Belbuca] require prior authorization?
82.5% of Part D formularies require prior authorization for buprenorphine 0.15 MG Buccal Film [Belbuca]. Step therapy: 0%. Quantity limits: 97.5%.
How much does Medicare spend on buprenorphine 0.15 MG Buccal Film [Belbuca]?
In 2023, total Medicare Part D spending on buprenorphine 0.15 MG Buccal Film [Belbuca] was $119,710,207, covering 74,893 beneficiaries. The average spend per beneficiary was $1,598.42.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
Similar prior-authorization rate
- ondansetron 4 MG Oral Tablet 82.3% PA
- ondansetron 8 MG Oral Tablet 82.3% PA
- ondansetron 8 MG Disintegrating Oral Tablet 82.3% PA
- ondansetron 4 MG Disintegrating Oral Tablet 82.3% PA
- methotrexate 2 MG/ML Oral Solution [Jylamvo] 82.9% PA
- 0.375 ML leuprolide acetate 60 MG/ML Prefilled Syringe [Eligard] 82.9% PA